Cargando…

Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis

Background: Antidepressant-induced excessive sweating (ADIES) is a common antidepressant-related side effect, and its prevalence is estimated to range from 4 - 22%. Adverse effects are a common reason for nonadherence and discontinuation of antidepressant medication, and alleviating these side effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Aditya., U, Raghuveer, Usha, L.V.R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129361/
http://dx.doi.org/10.4103/0019-5545.341924
_version_ 1784712734930108416
author Aditya., U
Raghuveer,
Usha, L.V.R
author_facet Aditya., U
Raghuveer,
Usha, L.V.R
author_sort Aditya., U
collection PubMed
description Background: Antidepressant-induced excessive sweating (ADIES) is a common antidepressant-related side effect, and its prevalence is estimated to range from 4 - 22%. Adverse effects are a common reason for nonadherence and discontinuation of antidepressant medication, and alleviating these side effects may improve adherence and promote positive outcomes Case description: We report 2 cases who were on antidepressants (SSRI) for anxiety disorder and major depressive disorder. After using the drug both patients developed excessive sweating over a period of time, which was found to be independent of their pre-existing condition. Stopping the drug helped in relieving sweating but when the drug was given again sweating recurred. Later on they were given with benztropine and glycopyrrolate which helped their symptoms successfully. Discussion: Adrenergic actions of antidepressants are implicated in causing ADIES. Agents that have been reported successful in controlling the sweating include benztropine and glycopyrrolate. Conclusion: We recommend a patient-specific approach for the management of ADIES. First, consider dose reduction or a trial off antidepressant medication. If patients in whom this is inappropriate or ineffective, substitution of other antidepressant may be considered. If episodes of excessive sweating persist, consider treatment with benztropine or glycopyrrolate or terazosin in the absence of contraindications.
format Online
Article
Text
id pubmed-9129361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-91293612022-05-25 Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis Aditya., U Raghuveer, Usha, L.V.R Indian J Psychiatry Abstract- Poster Background: Antidepressant-induced excessive sweating (ADIES) is a common antidepressant-related side effect, and its prevalence is estimated to range from 4 - 22%. Adverse effects are a common reason for nonadherence and discontinuation of antidepressant medication, and alleviating these side effects may improve adherence and promote positive outcomes Case description: We report 2 cases who were on antidepressants (SSRI) for anxiety disorder and major depressive disorder. After using the drug both patients developed excessive sweating over a period of time, which was found to be independent of their pre-existing condition. Stopping the drug helped in relieving sweating but when the drug was given again sweating recurred. Later on they were given with benztropine and glycopyrrolate which helped their symptoms successfully. Discussion: Adrenergic actions of antidepressants are implicated in causing ADIES. Agents that have been reported successful in controlling the sweating include benztropine and glycopyrrolate. Conclusion: We recommend a patient-specific approach for the management of ADIES. First, consider dose reduction or a trial off antidepressant medication. If patients in whom this is inappropriate or ineffective, substitution of other antidepressant may be considered. If episodes of excessive sweating persist, consider treatment with benztropine or glycopyrrolate or terazosin in the absence of contraindications. Wolters Kluwer - Medknow 2022-03 2022-03-24 /pmc/articles/PMC9129361/ http://dx.doi.org/10.4103/0019-5545.341924 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstract- Poster
Aditya., U
Raghuveer,
Usha, L.V.R
Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title_full Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title_fullStr Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title_full_unstemmed Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title_short Type of article: Case Report Title: Antidepressant induced excessive sweating (ADIES) or hyperhidrosis
title_sort type of article: case report title: antidepressant induced excessive sweating (adies) or hyperhidrosis
topic Abstract- Poster
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129361/
http://dx.doi.org/10.4103/0019-5545.341924
work_keys_str_mv AT adityau typeofarticlecasereporttitleantidepressantinducedexcessivesweatingadiesorhyperhidrosis
AT raghuveer typeofarticlecasereporttitleantidepressantinducedexcessivesweatingadiesorhyperhidrosis
AT ushalvr typeofarticlecasereporttitleantidepressantinducedexcessivesweatingadiesorhyperhidrosis